The healthcare system in GCC territories has become a growing concern in recent years. Beyond problems such as a growing population and a higher average lifespan, countries’ such as Saudi Arabia and Qatar have become host to some of the highest rates of chronic lifestyle diseases in the world. In the UAE, diabetes affects 19%…
China based conglomerate AUX Group has announced plans to seek health services investments in the US and Britain, according to recent reports. The company has 8.2 billion USD in total assets and was named among China’s top 500 enterprises. The announcement comes after AUX Group’s planned 2.7 billion AUD investment into Healthscope, the second-largest operator…
In May 2016, Chinese investment group Creat Group agreed to acquire UK-based Bio Products Laboratory for 820 million GBP (1.1 billion USD). Headquartered in Hertfordshire, Bio Products Laboratory is a plasma biotherapeutics company that provides therapeutics for conditions related to bleeding disorders, immune deficiencies and critical care. Creat will invest an additional 100 million GBP…
The Middle East is experiencing rising demand for high quality, innovative healthcare solutions. This is particularly true for the region’s largest healthcare market – Saudi Arabia. Saudi entities are increasingly willing to invest in healthcare companies overseas in order to source solutions and expertise that could meet the needs of the Saudi market. Healthcare is…
Investors based in the Middle East and regional healthcare companies having been actively seeking acquisitions and investment opportunities in the US. Overseas investments provide Middle Eastern individuals and institutions with a way to diversify their portfolios, rather than overexposing their operations to a single market, as noted recently in Forbes. According to Dhiraj Joshi, a…
Earlier this year, the pharmaceutical arm of Fosun International, a Chinese company with a market cap of over 13 billion USD, announced a1.3 billion USD buyout of India based Gland Pharma. Chinese companies are increasingly making healthcare deals abroad in order to become relevant and active players in the global healthcare market. The domestic market…
I-Bridge Capital, a health-care focused venture capital firm and incubator based in Shanghai, has announced the establishment of a joint venture with BioLineRx Ltd., a drug company based in Israel. The venture will incubate healthcare startups, in order to develop innovative clinical and pre-clinical therapeutic projects. Though these projects will originate primarily in Israel, they…
The investment arm of the Kingdom of Bahrain, Mumtalakat Holding Company, has announced the recent successful acquisition of an equity stake in KOS Group, a European healthcare group that provides long-term care and rehabilitation services, as well as hospital equipment management, cancer care services and diagnostics. Based in Italy, KOS Group operates over 76 dedicated…
The US healthcare sector is making rapid strides in recovering from the level of risk present in the sector in 2015. According to Michael Palumbo, founder of Third Millenium trading, the US healthcare sector “is now at a level where investors can begin to accumulate long positions without nearly the risk there was a year…
The Abu Dhabi Investment Authority, which has been the primary investment vehicle of the UAE government for the past 40 years, has seen a drop in its long-term gains. The fund’s assets are expected to drop to 475 billion USD at the end of 2016, down from an estimated 502 billion USD at the end…